Allogeneic vs. autologous mesenchymal stem/stromal cells in their medication practice
Allogeneic vs. autologous mesenchymal stem/stromal cells in their medication practice
About this item
Full title
Author / Creator
Li, Chenghai , Zhao, Hua , Cheng, Linna and Wang, Bin
Publisher
London: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Mesenchymal stem/stromal cell (MSC)-based therapeutics is already available for treatment of a range of diseases or medical conditions. Autologous or allogeneic MSCs obtained from self or donors have their own advantages and disadvantages in their medical practice. Therapeutic benefits of using autologous vs. allogeneic MSCs are inconclusive. Trans...
Alternative Titles
Full title
Allogeneic vs. autologous mesenchymal stem/stromal cells in their medication practice
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_b9a0181604a0473094a7f3f403ffd713
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b9a0181604a0473094a7f3f403ffd713
Other Identifiers
ISSN
2045-3701
E-ISSN
2045-3701
DOI
10.1186/s13578-021-00698-y
